Dueling federal rulings cloud abortion pill's future

Competing rulings by federal judges in Texas and Washington on Friday plunged the future of mifepristone, a key abortion drug, into uncertainty.

Related Keywords

Texas ,United States ,Amarillo ,Wichita ,Kansas ,Washington ,American ,America ,Lorie Chaiten ,Matthew Kacsmaryk ,Thomaso Rice ,Evan Masingill ,Terri Ann Thompson ,Erik Baptist ,Lupe Rodr ,Kamala Harris ,Joe Biden ,Jenny Ma ,Donald Trump ,Glenn Cohen ,Jack Resneck Jr ,Us Department Of Health ,Southern Poverty Law Center ,Ibis Reproductive Health ,District Court ,Centers For Disease ,Justice Department ,National Latina Institute For Reproductive Justice ,American College Of Obstetricians ,Women Kansas ,Alliance Defending Freedom ,Human Services ,Guttmacher Institute ,Supreme Court ,American Medical Association ,Supreme Court Justices ,Drug Administration ,Harvard Law School ,Us Supreme Court ,Christine Fernando ,Judge Matthew Kacsmaryk ,Judge Thomas ,Harvard Law ,Freedom Project ,Counsel Erik Baptist ,President Kamala Harris ,American College ,Medical Association President ,Jack Resneck ,General Merrick Garland ,Northern District ,Choice America ,President Donald Trump ,Defending Freedom ,Southern Poverty Law ,Ashley Brink ,Trust Women Kansas ,Disease Control ,Ann Thompson ,National Latina Institute ,Reproductive Justice ,Medication Abortion ,Food And Drug Administration ,Mifepristone ,Abortion Rights Advocates ,Government Approval ,Abortion ,Federal Judges ,